1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Base case results
Strategies Health Care Costs Effectiveness (QALY) Difference ICER^{^a} ($/QALY) Dominance
Costs Effectiveness
PET + MEG $95,612 16.30 – – 
SPECT + MEG $95,824 16.28 $212^{^b} −0.0241^{^b} – Dominated
PET + SPECT $96,532 16.36 $920^{^b} 0.0543^{^b} $16,937^{^c} Ext. Dominated
SPECT $97,479 16.45 $1867^{^b} 0.1443^{^b} $12,934^{^c} 
MEG $97,499 16.42 $21 −0.0238^{^d} – Dominated
PET $97,623 16.44 $144 −0.0121^{^d} – Dominated
Note:— – indicates XXX; Ext., extended.
↵a The results of incremental effectiveness and ICER may not show as the calculated value based on the “Effectiveness” column due to round-up.
↵b The result of incremental cost and incremental effectiveness was compared with strategy 1—PET+MEG.
↵c The ICER was calculated when the strategies were compared with strategy 1—PET+MEG.
↵d The results of incremental effectiveness were compared with strategy 4—SPECT.